FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Some
    2 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Aspirin 325 mg and methocarbamol 400 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Aspirin 81 mg and pravastatin 20 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Codeine phosphate 30 mg and paracetamol 500 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Aspirin 81 mg and pravastatin 40 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Aspirin 81 mg and pravastatin 80 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Butalbital 50 mg and paracetamol 325 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Aspirin 325 mg and pravastatin 80 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Aspirin 325 mg and pravastatin 40 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Atenolol 100 mg and chlortalidone 25 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine 5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Atenolol 50 mg and chlortalidone 25 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Chlorothiazide 250 mg and methyldopa 250 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Chlorothiazide 250 mg and reserpine 125 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine 10 milligram and telmisartan 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Atenolol 50 mg and chlortalidone 12.5 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Desogestrel 150 microgram and ethinylestradiol 20 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely ampicillin 250 milligram and flucloxacillin 250 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Choline bitartrate 25 mg and dexpanthenol 50 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amitriptyline 25 milligram and perphenazine 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amitriptyline 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Caffeine 25 mg and paracetamol 450 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amitriptyline 25 milligram and perphenazine 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amitriptyline 50 milligram and perphenazine 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Codeine phosphate 20 mg and ibuprofen 300 mg prolonged-release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Amobarbital sodium 100 mg and secobarbital sodium 100 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Butalbital 50 mg and paracetamol 650 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some

    Start Page 2 of 24 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start